» Articles » PMID: 27683113

ESM1 Mediates NGFR-induced Invasion and Metastasis in Murine Oral Squamous Cell Carcinoma

Overview
Journal Oncotarget
Specialty Oncology
Date 2016 Sep 30
PMID 27683113
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Oral squamous cell carcinoma (OSCC) is a highly invasive and metastatic malignancy. The nerve growth factor receptor (NGFR) has been observed to be expressed on a subset of cells in OSCC, and NGFR+ cells have greater tumor-initiating capacity in vivo. Further, inhibition of NGFR reduces tumor growth, indicating a functional role of this receptor; however, the mechanisms by which NGFR confers enhanced tumor formation are not known. Here, we used an established murine model of OSCC and gene expression array analysis to identify ESM1 as a downstream target gene of NGFR, critical for tumor invasion and metastasis. ESM1 encodes a protein called endocan, which has the property of regulating proliferation, differentiation, migration, and adhesion of different cell types. Incubation of NGFR+ murine OSCC cells with nerve growth factor resulted in increased expression of ESM1. Importantly, ESM1 overexpression conferred an enhanced migratory, invasive, and metastatic phenotype, similar to what has been correlated with NGFR expression. Conversely, shRNA knockdown of ESM1 in NGFR overexpressing OSCC cells abrogated the tumor growth kinetics and the invasive and metastatic properties associated with NGFR. Together, our data indicate that NGFR plays an important role in the pathogenesis and progression of OSCC via regulation of ESM1.

Citing Articles

An antisense-long-noncoding-RNA modulates p75 expression levels during neuronal polarization.

De Paolis V, Paolillo N, Siri T, Grosso A, Lorello V, Spina C iScience. 2025; 28(1):111566.

PMID: 39811648 PMC: 11730960. DOI: 10.1016/j.isci.2024.111566.


Validation of ESM1 Related to Ovarian Cancer and the Biological Function and Prognostic Significance.

Li Y, Zeng T, Guan Y, Liu J, Liao N, Wang M Int J Biol Sci. 2023; 19(1):258-280.

PMID: 36594088 PMC: 9760436. DOI: 10.7150/ijbs.66839.


The mouse oral carcinoma (MOC) model: A 10-year retrospective on model development and head and neck cancer investigations.

Kono M, Saito S, Egloff A, Allen C, Uppaluri R Oral Oncol. 2022; 132:106012.

PMID: 35820346 PMC: 9364442. DOI: 10.1016/j.oraloncology.2022.106012.


Prolactin (PRL), placenta growth factor (PIGF) and nerve growth factor receptor (NGFR) as biomarkers for early diagnosis and prognosis in patients with esophageal squamous cell carcinoma (ESCC).

Ai X, Zhu X, Zuo J Transl Cancer Res. 2022; 9(2):647-656.

PMID: 35117410 PMC: 8798035. DOI: 10.21037/tcr.2019.12.31.


Targeting Endothelial Cell-Specific Molecule 1 Protein in Cancer: A Promising Therapeutic Approach.

Zhang H, Shen Y, Zhang L, Chen J, Bian H, Gu W Front Oncol. 2021; 11:687120.

PMID: 34109132 PMC: 8181400. DOI: 10.3389/fonc.2021.687120.


References
1.
Hatfield K, Lassalle P, Leiva R, Lindas R, Wendelboe O, Bruserud O . Serum levels of endothelium-derived endocan are increased in patients with untreated acute myeloid leukemia. Hematology. 2011; 16(6):351-6. DOI: 10.1179/102453311X13127324303434. View

2.
Matano F, Yoshida D, Ishii Y, Tahara S, Teramoto A, Morita A . Endocan, a new invasion and angiogenesis marker of pituitary adenomas. J Neurooncol. 2014; 117(3):485-91. DOI: 10.1007/s11060-014-1377-6. View

3.
Rapidis A, Gullane P, Langdon J, LeFebvre J, Scully C, Shah J . Major advances in the knowledge and understanding of the epidemiology, aetiopathogenesis, diagnosis, management and prognosis of oral cancer. Oral Oncol. 2009; 45(4-5):299-300. DOI: 10.1016/j.oraloncology.2009.04.001. View

4.
Forsberg L, Rasi C, Pekar G, Davies H, Piotrowski A, Absher D . Signatures of post-zygotic structural genetic aberrations in the cells of histologically normal breast tissue that can predispose to sporadic breast cancer. Genome Res. 2015; 25(10):1521-35. PMC: 4579338. DOI: 10.1101/gr.187823.114. View

5.
Miao Y, Zong M, Jiang T, Yuan X, Guan S, Wang Y . A comparative analysis of ESM-1 and vascular endothelial cell marker (CD34/CD105) expression on pituitary adenoma invasion. Pituitary. 2016; 19(2):194-201. PMC: 4799238. DOI: 10.1007/s11102-015-0698-6. View